We report the discovery of Zr 3 Ir as a structurally different type of unconventional noncentrosymmetric superconductor (with T c = 2.3 K), here investigated mostly via muon-spin rotation/relaxation (μSR) techniques. Its superconductivity was characterized using magnetic susceptibility, electrical resistivity, and heat capacity measurements. The low-temperature superfluid density, determined via transverse-field μSR and electronic specific heat, suggests a fully gapped superconducting state. The spontaneous magnetic fields, revealed by zero-field μSR below T c , indicate the breaking of time-reversal symmetry in Zr 3 Ir and hence the unconventional nature of its superconductivity. By using symmetry arguments and electronic-structure calculations we obtain a superconducting order parameter that is fully compatible with the experimental observations. Hence, our results clearly suggest that Zr 3 Ir represents a structurally different member of noncentrosymmetric superconductors with broken time-reversal symmetry.
Lung cancer is considered among the deadliest cancers with a poor prognosis. Au@PG nanoparticles (NPs) are gold (Au)-based NPs featuring a polyaniline-based glyco structure (PG) generated from the polymerization of ortho-nitrophenyl-β-d-galactopyranoside (ONPG) with promising M1 macrophage polarization activity, resulting in tumor remodeling and from a cold to a hot microenvironment, which promotes the cytotoxic T cell response and tumor inhibition. The combination of Au@PG NPs and anti-programmed cell death protein 1 (PD-1) therapy improved tumor inhibition and immunosuppression, accompanied by the secretion of immunogenic cytokines. A one-pot synthetic method was developed to achieve glyco-condensation during the formation of Au@PG NPs, which induced macrophage polarization more efficiently than Au@glucose, Au@mannose, and Au@galactose NPs. The switch from M2 to M1 macrophages was dependent on NP size, with smaller Au@PG NPs performing better than larger ones, with effectiveness ranked as follows: 32.2 nm ≈ 29.8 nm < 26.4 nm < 18.3 nm. Cellular uptake by endocytosis induced size-dependent endoplasmic reticulum (ER) stress, which resulted in the activation of spleen tyrosine kinase (SYK), leading to immune modulations and macrophage polarization. Our results suggested the promising potential of Au@PG NPs in lung cancer immunotherapy.
We report the single-crystal synthesis and detailed investigations of the cage-type superconductor ScRuSn, using powder x-ray diffraction (XRD), magnetization, specific-heat and muon-spin relaxation (µSR) measurements. ScRuSn crystallizes in a tetragonal structure (space group I4/acd) with lattice parameters a = 1.387(3) nm and c = 2.641(5) nm. Both DC and AC magnetization measurements prove the type-II superconductivity in ScRuSn with T ≈ 3.5(1) K, a lower critical field [Formula: see text] = 157(9) Oe and an upper critical field, [Formula: see text] = 26(1) kOe. The zero-field electronic specific-heat data are well fitted using a single-gap BCS model, with [Formula: see text] = 0.64(1) meV. The Sommerfeld constant γ varies linearly with the applied magnetic field, indicating s-wave superconductivity in ScRuSn. Specific-heat and transverse-field (TF) µSR measurements reveal that ScRuSn is a superconductor with strong electron-phonon coupling, with TF-µSR also suggesting a single-gap s-wave character of the superconductivity. Furthermore, zero-field µSR measurements do not detect spontaneous magnetic fields below T , hence implying that time-reversal symmetry is preserved in ScRuSn.
Herein, we employ a galvanic replacement approach to create atomically dispersed Au on degradable zero-valent Cu nanocubes for tumor treatments on female mice. Controlling the addition of precursor HAuCl4 allows for the fabrication of different atomic ratios of AuxCuy. X-ray absorption near edge spectra indicates that Au and Cu are the predominant oxidation states of zero valence. This suggests that the charges of Au and Cu remain unchanged after galvanic replacement. Specifically, Au0.02Cu0.98 composition reveals the enhanced •OH generation following O2 → H2O2 → •OH. The degradable Au0.02Cu0.98 released Cu+ and Cu2+ resulting in oxygen reduction and Fenton-like reactions. Simulation studies indicate that Au single atoms boot zero-valent copper to reveal the catalytic capability of Au0.02Cu0.98 for O2 → H2O2 → •OH as well. Instead of using endogenous H2O2, H2O2 can be sourced from the O2 in the air through the use of nanocubes. Notably, the Au0.02Cu0.98 structure is degradable and renal-clearable.
Ineffective site-specific delivery has seriously impeded the efficacy of nanoparticle-based drugs to a disease site. Here, we report the preparation of three different shapes (sphere, scroll, and oblate) to systematically evaluate the impact of the marginative delivery on the efficacy of magnetic resonance (MR) imaging-guided X-ray irradiation at a low dose of 1 Gy. In addition to the shape effect, the therapeutic efficacy is investigated for the first time to be strongly related to the structure effect that is associated with the chemical activity. The enhanced particle–vessel wall interaction of both the flat scroll and oblate following margination dynamics leads to greater accumulation in the lungs, resulting in superior performance over the sphere against lung tumor growth and suppression of lung metastasis. Furthermore, the impact of the structural discrepancy in nanoparticles on therapeutic efficacy is considered. The tetragonal oblate reveals that the feasibility of the charge-transfer process outperforms the orthorhombic scroll and cubic sphere to suppress tumors. Finally, surface area is also a crucial factor affecting the efficacy of X-ray treatments from the as-prepared particles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.